NO161036C - Fremgangsmaate ved fremstilling av et frysetoerret, farmasoeytisk interferonpreparat. - Google Patents

Fremgangsmaate ved fremstilling av et frysetoerret, farmasoeytisk interferonpreparat.

Info

Publication number
NO161036C
NO161036C NO82824285A NO824285A NO161036C NO 161036 C NO161036 C NO 161036C NO 82824285 A NO82824285 A NO 82824285A NO 824285 A NO824285 A NO 824285A NO 161036 C NO161036 C NO 161036C
Authority
NO
Norway
Prior art keywords
preparation
procedure
pharmaceutical
freezer
dry
Prior art date
Application number
NO82824285A
Other languages
English (en)
Other versions
NO161036B (no
NO824285L (no
Inventor
Henry King Hong Kwan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26989028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO161036(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ZA828580A external-priority patent/ZA828580B/xx
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO824285L publication Critical patent/NO824285L/no
Publication of NO161036B publication Critical patent/NO161036B/no
Publication of NO161036C publication Critical patent/NO161036C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
NO82824285A 1981-12-23 1982-12-20 Fremgangsmaate ved fremstilling av et frysetoerret, farmasoeytisk interferonpreparat. NO161036C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33405281A 1981-12-23 1981-12-23
ZA828580A ZA828580B (en) 1981-12-23 1982-11-19 Interferon formulations

Publications (3)

Publication Number Publication Date
NO824285L NO824285L (no) 1983-06-24
NO161036B NO161036B (no) 1989-03-20
NO161036C true NO161036C (no) 1989-06-28

Family

ID=26989028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO82824285A NO161036C (no) 1981-12-23 1982-12-20 Fremgangsmaate ved fremstilling av et frysetoerret, farmasoeytisk interferonpreparat.

Country Status (18)

Country Link
US (1) US4496537A (no)
EP (1) EP0082481B2 (no)
AU (1) AU558966B2 (no)
CA (1) CA1207665A (no)
DE (1) DE3262575D1 (no)
DK (1) DK158873C (no)
FI (1) FI70794C (no)
HK (1) HK94487A (no)
HU (1) HU190649B (no)
IE (1) IE54468B1 (no)
IL (1) IL67517A (no)
MY (1) MY8700705A (no)
NO (1) NO161036C (no)
NZ (1) NZ202856A (no)
OA (1) OA07282A (no)
PH (1) PH19869A (no)
PT (1) PT76013B (no)
SG (1) SG70687G (no)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600583A (en) * 1982-09-07 1986-07-15 Tetra Consultants Inc. Pharmaceutical compositions
US4469228A (en) * 1983-05-31 1984-09-04 Schering Corporation Interferon kit
JPH0651641B2 (ja) * 1983-08-29 1994-07-06 株式会社ミドリ十字 ガンマ・インターフェロン組成物
JPS6034919A (ja) * 1983-08-04 1985-02-22 Green Cross Corp:The ガンマ・インタ−フェロン組成物
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
JPS60243028A (ja) * 1984-04-28 1985-12-03 Kyowa Hakko Kogyo Co Ltd インタ−フエロンの可溶化方法
EP0168008A3 (en) * 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
US4847079A (en) * 1985-07-29 1989-07-11 Schering Corporation Biologically stable interferon compositions comprising thimerosal
DE3628468A1 (de) * 1986-08-21 1988-03-03 Thomae Gmbh Dr K Neue applikationsformen fuer (alpha)-interferone
CA1320905C (en) 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
US4871538A (en) * 1987-07-13 1989-10-03 Schering Corporation Insoluble copper-alpha interferon complex
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
ES2058351T3 (es) * 1988-01-29 1994-11-01 Sumitomo Pharma Un procedimiento para producir una formulacion de liberacion sostenida que es adecuada para el uso humano y veterinario.
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
IT1240314B (it) * 1989-09-28 1993-12-07 Immunobiology Research Institutes, Inc. Formulazioni acquose stabilizzate di piccoli peptidi.
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
AU669132B2 (en) * 1991-10-11 1996-05-30 Mark Cedric Gillies Treating ophthalmic fibrosis using interferon-alpha
WO1993006856A1 (en) * 1991-10-11 1993-04-15 Mark Cedric Gillies Treating ophthalmic fibrosis using interferon-alpha
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
LT3987B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Stabilized interferon compositions
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
US6270757B1 (en) * 1994-04-21 2001-08-07 Genetics Institute, Inc. Formulations for IL-11
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
US5766582A (en) * 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
DE69620877T2 (de) * 1995-02-06 2002-12-12 Genetics Institute, Inc. Arzneimittelformulierungen für il-12
US5656730A (en) * 1995-04-07 1997-08-12 Enzon, Inc. Stabilized monomeric protein compositions
US6540993B1 (en) 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US6126933A (en) * 1995-06-27 2000-10-03 Genetics Institute Methods of treating inflammatory bowel diseases by administering IL-11
CA2275890C (en) * 1996-12-24 2011-11-01 Biogen, Inc. Stable liquid interferon formulations
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
IL135186A0 (en) † 1997-09-23 2001-05-20 Rentschler Biotechnologie Bmgh LIQUID INTERFERON-β FORMULATIONS
US7230014B1 (en) 1997-10-14 2007-06-12 Eisai Co., Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
DK1039905T3 (da) * 1997-10-14 2006-11-06 Eisai Co Ltd Farmaceutisk formulering omfattende glycin som en stabilisator
US20040019923A1 (en) * 1997-10-16 2004-01-29 Ivarie Robert D. Exogenous proteins expressed in avians and their eggs
US7511120B2 (en) * 1997-10-16 2009-03-31 Synageva Biopharma Corp. Glycosylated G-CSF obtained from a transgenic chicken
US20090074718A1 (en) * 1997-10-16 2009-03-19 Ivarie Robert D Avian derived erythropoietin
US8563803B2 (en) * 1997-10-16 2013-10-22 Synageva Biopharma Corp. Method of making protein in an egg of a transgenic chicken
US7129390B2 (en) * 1997-10-16 2006-10-31 Avigenics, Inc Poultry Derived Glycosylated Interferon Alpha 2b
US20030166525A1 (en) * 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
US6281337B1 (en) 1998-11-12 2001-08-28 Schering Corporation Methods for conversion of protein isoforms
PT1894944E (pt) 1998-11-12 2010-10-28 Schering Corp Métodos para a conversão de isoformas de interferão e seus produtos
DE60019458T2 (de) * 1999-12-14 2006-02-23 Thermo BioStar, Inc., Boulder Stabilisierendes verdünnungsmittel für polypeptide und antigene
JP2004537964A (ja) 2000-11-03 2004-12-24 ペストカ バイオメディカル ラボラトリーズ インコーポレイテッド インターフェロン、それに関する使用及び組成物
CA2680475A1 (en) 2000-12-28 2002-07-11 Shigeyuki Takada Sustained-release preparation
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
KR100964411B1 (ko) 2002-01-18 2010-06-15 바이오겐 아이덱 엠에이 인코포레이티드 생물학적 활성 화합물과 컨쥬게이팅되는 잔기를 갖는 폴리알킬렌 글리콜
US6830744B2 (en) 2002-05-31 2004-12-14 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
US20050232899A1 (en) * 2002-05-31 2005-10-20 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
US7803362B2 (en) * 2003-01-24 2010-09-28 Synageva Biopharma Corp. Glycosylated interferon alpha
JP4699991B2 (ja) * 2003-04-02 2011-06-15 アレス トレーディング ソシエテ アノニム 非イオン性界面活性剤を一緒に伴うｆｓｈ及びｌｈの液体医薬組成物
WO2004112826A1 (en) * 2003-06-20 2004-12-29 Ares Trading Sa Freeze-dried fsh / lh formulations
EP1796647B1 (en) * 2004-08-12 2010-08-11 Schering Corporation Stable pegylated interferon formulation
US20080064862A1 (en) * 2004-12-29 2008-03-13 Avigenics, Inc. Transgene expression in a avians
US20080299212A1 (en) * 2005-02-25 2008-12-04 Medigenes Co., Ltd Pharmaceutical Composition for Treating Avellino Cornea Dystrophy Comprising Blood Plasma or Serum
US8124732B2 (en) 2005-06-24 2012-02-28 Synageva Biopharma Corp. Composition comprising isolated human CTLA4-Fc fusion protein produced in a transgenic chicken
US20070003564A1 (en) * 2005-06-30 2007-01-04 Hurley John K Diluent for immunohistochemistry
US7931919B2 (en) * 2005-08-12 2011-04-26 The United States Of America As Represented By The Secretary Of The Army Method of producing glycine-stabilized, lyophilized plasma
CU23432B6 (es) 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
US7812127B2 (en) 2006-03-17 2010-10-12 Synageva Biopharma Corp. Glycosylated human G-CSF
US20090105462A1 (en) * 2006-11-09 2009-04-23 Ivarie Robert D Glycosylated erythropoietin
PL2097068T3 (pl) * 2006-11-24 2013-12-31 Cadila Healthcare Ltd Preparaty koniugatów PEG-interferon alfa
US7951368B2 (en) 2007-06-25 2011-05-31 Amgen Inc. Compositions of specific binding agents to hepatocyte growth factor
WO2009079837A1 (fr) * 2007-12-18 2009-07-02 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Formulation pharmaceutique contenant une protéine de fusion sérum albumine humaine recombinante-interféron alpha
EP2496246B1 (en) 2009-11-03 2018-06-27 Grifols Therapeutics LLC Composition, method, and kit for alpha-1 proteinase inhibitor
KR101567901B1 (ko) 2009-11-24 2015-11-10 그리폴스 테라퓨틱스 인코포레이티드 동결건조 방법, 조성물, 및 키트
US20130008191A1 (en) * 2011-07-07 2013-01-10 Suchak Naresh J Methods for freezing and thawing proteins
US11318207B2 (en) 2014-08-19 2022-05-03 Biogen Ma Inc. Pegylation method
CN106421755A (zh) * 2016-11-03 2017-02-22 广州凯耀资产管理有限公司 一种干扰素组合物及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553497A (en) * 1946-02-04 1951-05-15 L Inst De Serotherapie Hemopoi Hemostatic composition of thrombin and glycocoll
US2806815A (en) * 1955-04-12 1957-09-17 Ortho Pharma Corp Stabilized hyaluronidase
GB866423A (en) * 1958-03-21 1961-04-26 Armour & Co Improvements in or relating to chymotrypsin solutions
US3016398A (en) * 1959-04-06 1962-01-09 Staley Mfg Co A E Stabilized phytic acid solutions and methods of preparation thereof
GB900115A (en) * 1960-06-15 1962-07-04 Armour & Co Improvements in or relating to trypsin solutions
JPS5495795A (en) * 1978-01-13 1979-07-28 Toray Ind Inc Production of interferon
IN150740B (no) * 1978-11-24 1982-12-04 Hoffmann La Roche
JPS55102519A (en) * 1979-01-31 1980-08-05 Green Cross Corp:The Stabilization of interferon
US4198479A (en) * 1979-03-30 1980-04-15 Merck & Co., Inc. Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells
US4252791A (en) * 1979-10-19 1981-02-24 The Medical College Of Wisconsin, Inc. Interferon stabilization
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation

Also Published As

Publication number Publication date
EP0082481B1 (en) 1985-03-13
IL67517A0 (en) 1983-05-15
IL67517A (en) 1988-11-30
AU9168882A (en) 1983-06-30
NZ202856A (en) 1985-12-13
NO161036B (no) 1989-03-20
NO824285L (no) 1983-06-24
OA07282A (fr) 1984-11-30
DE3262575D1 (en) 1985-04-18
AU558966B2 (en) 1987-02-19
CA1207665A (en) 1986-07-15
SG70687G (en) 1988-02-19
US4496537A (en) 1985-01-29
HK94487A (en) 1987-12-18
DK158873C (da) 1990-12-31
DK565882A (da) 1983-06-24
MY8700705A (en) 1987-12-31
PT76013B (en) 1986-03-11
HU190649B (en) 1986-09-29
DK158873B (da) 1990-07-30
FI824366A0 (fi) 1982-12-20
PT76013A (en) 1983-01-01
EP0082481B2 (en) 1990-09-12
FI70794B (fi) 1986-07-18
FI70794C (fi) 1986-10-27
PH19869A (en) 1986-08-13
FI824366L (fi) 1983-06-24
IE54468B1 (en) 1989-10-25
DK158771B (da) 1990-07-16
IE823046L (en) 1983-06-23
EP0082481A1 (en) 1983-06-29

Similar Documents

Publication Publication Date Title
NO161036C (no) Fremgangsmaate ved fremstilling av et frysetoerret, farmasoeytisk interferonpreparat.
FI822005L (fi) Antifungisida aemnen, foerfarande foer deras framstaellning, och dessa innehaollande farmaceutiska sammansaettningar
ES509449A0 (es) "un procedimiento de preparacion de derivados de 1,3-dihidro-6-metil-7-hidroxi-furo-3,4-c-piridina".
NO170071C (no) Fremgangsmaate ved fremstilling av klordioksyd.
IT7926935A0 (it) Procedimento eterogeneo per lapreparazione di 1,1-diesteri.
NO166032C (no) Fremgangsmaate ved fremstilling av triklormonosilan.
NO163042C (no) Fremgangsm te ved fremstilling av stabiliserte pge2ndelser.
FI823544A0 (fi) Triazinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar
NO160206C (no) Fremgangsmaate ved fremstilling av isosilybinfri silibinin.
NO884665D0 (no) Fremgangsmaate ved fremstilling av 9-oh-alkoksyguanin.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO153431C (no) Fremgangsmaate ved fremstilling av 6alfa-halogen-3-keto-delta1,4-pregnadiener.
NO860794L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO831673L (no) Fremgangsmaate ved fremstilling av roerkokiller.
NO852810L (no) Fremgangsmaate ved fremstilling av fluorallylaminderivater.
NO165676C (no) Fremgangsmaate ved fremstilling av pyrrolidonderivater.
NO157421C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3,7-diazabicyclo-(3.3.1)-nonan-derivater.
NO162519C (no) Fremgangsmaate ved fremstilling av alkylenkarbonat.
NO153951C (no) Fremgangsmaate for fremstilling av en farmasoeytisk tilberedning som inneholder 8-metoksy-furo-(3[ ,2[:6,7)-cumarin.
NO864386D0 (no) Fremgangsmaate ved fremstilling av uretaner.
NO165538C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO822801L (no) Fremgangsmaate ved fremstilling av terapeutisk aktivt 2,5 disubstituerte furaner
NO156751B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive p-oxooxazolidinylbenzensulfonamider.
NL193821B (nl) Farmaceutisch preparaat.
ES480137A0 (es) Un procedimiento de preparacion de nuevos de- rivados de 1,3-benzodioxina.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN DECEMBER 2003